18 analysts have coverage on Gland Pharma, of which 11 have a “buy” rating, two say “hold”, while five have a “sell” rating.
18 analysts have coverage on Gland Pharma, of which 11 have a “buy” rating, two say “hold”, while five have a “sell” rating.